TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05118711

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung function
Description: Body plethysmography

Intervention type: DIAGNOSTIC_TEST
Intervention: Muscular strength and balance tests
Description: Handgrip strength test, mid-thigh pull test and standing balance test in static tandem stance

Intervention type: DIAGNOSTIC_TEST
Intervention: Muscular strength and balance tests
Description: Handgrip strength test, mid-thigh pull test and standing balance test in static tandem stance

Intervention type: DIAGNOSTIC_TEST
Intervention: Micro- and macrovascular endothelial function and cardiac function
Description: Measurement of flow-mediated dilation, static and dynamic retinal vessel analysis, echocardiography
Study: NCT04543877

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ty21a Typhoid Fever Vaccine
Description: All participants will receive the vaccine. One capsule is swallowed on alternate days, e.g. days 30, 32, 34, and 36 for a total of 4 capsules.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Ty21a Typhoid Fever Vaccine
Description: All participants will receive the vaccine. One capsule is swallowed on alternate days, e.g. days 30, 32, 34, and 36 for a total of 4 capsules.
Study: NCT05118711

Intervention type: DIAGNOSTIC_TEST
Intervention: Micro- and macrovascular endothelial function and cardiac function
Description: Measurement of flow-mediated dilation, static and dynamic retinal vessel analysis, echocardiography

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling and analysis
Description: Blood sampling by venepuncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling and analysis
Description: Blood sampling by venepuncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Physical activity
Description: Physical activity surveillance using accelerometers

Intervention type: DIAGNOSTIC_TEST
Intervention: Physical activity
Description: Physical activity surveillance using accelerometers

Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires
Description: Global physical activity questionnaire (GPAQ), short-form 8 health survey (SF-8), barriers to physical activity, fatigue assessment scale (FAS), modified medical research council dyspnea scale (mMRC), depression, anxiety, and stress scale (DASS21), post-COVID-19 syndrome symptoms

Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires
Description: Global physical activity questionnaire (GPAQ), short-form 8 health survey (SF-8), barriers to physical activity, fatigue assessment scale (FAS), modified medical research council dyspnea scale (mMRC), depression, anxiety, and stress scale (DASS21), post-COVID-19 syndrome symptoms

Intervention type: DIAGNOSTIC_TEST
Intervention: Body composition
Description: Dual-energy x-ray absorptiometry (DXA)

Intervention type: DIAGNOSTIC_TEST
Intervention: Body composition
Description: Dual-energy x-ray absorptiometry (DXA)
Study: NCT05097833

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Saint Francis Fatherhood FIRE Program
Description: Fathers receive an enhanced series of pro-parenting, relationship, and economic stability workshops over 16 weeks. Workshop series are based on a diverse curricula including a combination of either 24/7 Dad or Parent Project and Connections to Success and the Nurturing Fathers enhancement program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Services as Usual Saint Francis Fatherhood FIRE Program
Description: Fathers receive the services as usual approach which includes a series of pro-parenting, relationship, and economic stability workshops over 13 weeks. Workshop series are based on a diverse curricula including a combination of either 24/7 Dad or Parent Project and Connections to Success.
Study: NCT06184542

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTacP (one-dose booster)
Description: Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on Day 0
Study: NCT04907253

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quercetin
Description: 500 mg twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: twice daily
Study: NCT06418737

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep HygieneTraining
Description: Training Content~* Importance of Sleep: The vital importance of sleep for physical and mental health.~* Benefits of Adequate and Quality Sleep: The numerous benefits of sufficient and good quality sleep.~* Sleep Stages: The different stages of sleep and their characteristics.~* Sleep Hygiene: The concept of sleep hygiene and its importance for improving sleep quality.~* What to Do?~* What to Avoid for Better Sleep?
Study: NCT06429709

Intervention type: DEVICE
Intervention: Advanced Ultrasound Otoscope
Description: The Advanced Ultrasound Otoscope is a tool for visualization of the human tympanic membrane and detection of middle ear effusion type

Intervention type: DEVICE
Intervention: Advanced Ultrasound Otoscope
Description: The Advanced Ultrasound Otoscope is a tool for visualization of the human tympanic membrane and detection of middle ear effusion type
Study: NCT04873440

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Manganese Chloride
Description: Administered by inhalation at 0.4mg/kg/d twice a week
Study: NCT06184542

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTacP (one-dose booster)
Description: Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on Day 0

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTacP (three-dose primary vaccination)
Description: Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on the M3-M4-M5, M2-M3-M4, or M2-M4-M6 immunization schedule

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTacP (three-dose primary vaccination)
Description: Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on the M3-M4-M5, M2-M3-M4, or M2-M4-M6 immunization schedule

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTacP (three-dose primary vaccination)
Description: Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on the M3-M4-M5, M2-M3-M4, or M2-M4-M6 immunization schedule

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DT (one-dose booster)
Description: Diphtheria-Tetanus Combined Vaccine of 0.5mL on Day 0
Study: NCT04873440

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Measurable lesions were targeted for radiotherapy at the discretion of the treating physician.Standard-of-care radiotherapy or SBRT were both allowed.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemo-immunotherapy
Description: The same chemotherapy and/or anti-PD-1 therapy before thei patients' enrolment were allowed. Whether and which should be given depends on the treatment regimen before enrollment.
Study: NCT06184542

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DTaP (one-dose booster)
Description: Diphtheria-Tetanus-acellular Pertussis Vaccine of 0.5mL on Day 0
Study: NCT04703192

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valemetostat Tosylate
Description: Oral administration of valemetostat tosylate at a dose of 200 mg once daily starting at Cycle 1, Day 1 (continuous for 28-day cycles), until disease progression or unacceptable toxicity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valemetostat Tosylate
Description: Oral administration of valemetostat tosylate at a dose of 200 mg once daily starting at Cycle 1, Day 1 (continuous for 28-day cycles), until disease progression or unacceptable toxicity
Study: NCT06184542

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PENTAXIM (one-dose booster)
Description: Diphtheria, Tetanus, acellular Pertussis, inactivated Polio, conjugate Haemophilus influenzae type b Combined Vaccine of 0.5mL on Day 0

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DTaP (three-dose primary vaccination)
Description: Diphtheria-Tetanus-acellular Pertussis Vaccine of 0.5mL on an M3-M4-M5immunization schedule
Study: NCT05451589

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RESET
Description: RESET consists of 7 weekly group phone sessions led by Community Health Workers, along with an accompanying podcast series.Topics will include positive psychology, physical activity, social connection, eating well, relaxation, and more. There will be one individual session with the Community Health Worker to screen for unmet social needs and to offer connections to resources as needed. In the group sessions, participants will set goals incorporating positive activities and strategies to improve daily functioning. Up-to-date information related to COVID-19 prevention and treatment will be provided.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wellness Check Control
Description: After completing the baseline survey, control group participants will be mailed an educational packet consisting of information about COVID-19 prevention and treatment, as well as essential community resources. Control group participants will also be invited to take part in a wellness check telephone session with a Community Health Worker, about a half-hour long, at which a social needs screener will be administered, and any needed referrals will be made. After completing the 8-month follow up, they will have the opportunity to participate in the full intervention.
Study: NCT05356988

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity experiment
Description: The Physical Activity (PA) group will have access for one year to the PA website to help increase aerobic and strength training activities.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Balance and flexibility control
Description: The static Balance and Flexibility (BF) website will include infographics, videos, and articles for participants to view at their leisure around stretching and balance exercises.
Study: NCT06133556

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MCBC regimen
Description: using MCBC as conditioning regimen, Mel 60mg/ m2 -9\~-8d, Cladribine 5 mg/m2 -9\~-5d, Bu3.2mg/kg -5\~-3d； Cy 30mg/kg -2\~-1 d

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bu/Cy regimen
Description: control group, the standard conditioning regimen Busulfan/Cyclophosphamide
Study: NCT06184542

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PENTAXIM (three-dose primary vaccination)
Description: Diphtheria, Tetanus, acellular Pertussis, inactivated Polio, conjugate Haemophilus influenzae type b Combined Vaccine of 0.5mL on the M3-M4-M5 or M2-M3-M4 immunization schedule

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PENTAXIM (three-dose primary vaccination)
Description: Diphtheria, Tetanus, acellular Pertussis, inactivated Polio, conjugate Haemophilus influenzae type b Combined Vaccine of 0.5mL on the M3-M4-M5 or M2-M3-M4 immunization schedule
Study: NCT05604573

Intervention type: DIAGNOSTIC_TEST
Intervention: cell free DNA in blood, genetic mutation in tissue
Description: Diagnostic test for cell free DNA in blood, genetic mutation in tissue

Intervention type: DIAGNOSTIC_TEST
Intervention: cell free DNA in blood, genetic mutation in tissue
Description: Diagnostic test for cell free DNA in blood, genetic mutation in tissue
Study: NCT05879731

Intervention type: OTHER
Intervention: EEG-hd (high density electroencephalogram)
Description: Once in the operating room, the investigators will place a 128-channel Hd-EEG (high density electroencephalogram) saline net referenced to Cz on the patient's head. Impedances will be verified and maintained \<50 kΩ for the duration of the study. The patient will be positioned supine and all routine monitors will be installed. A 5 minutes baseline resting-state Hd-EEG with eyes closed will be performed before induction. Once under general anesthesia and intubated, a no pain period of 5 minutes will take place. During this 5-min period, resting-state Hd-EEG recording will be recorded. A standardized tetanic stimulation to the ulnar nerve of the non-dominant forearm delivered by a routine nerve stimulator (100 Hz, 70 mA) for a duration of 30 seconds will then be applied. Hd-EEG recording will take place during this 30 seconds and will continue during the 5 minutes after. Once this period will be over, the Hd-EEG net will be removed and the investigators will exit the operating room.
Study: NCT05145699

Intervention type: DEVICE
Group type: OTHER
Intervention: VR-based post-stroke hemineglect evaluation system
Description: Evaluation system applied with virtual environment using Pico Neo 2 eye

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VR-based post-stroke hemineglect evaluation system
Description: Evaluation system applied with virtual environment using Pico Neo 2 eye

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VR-based post-stroke hemineglect evaluation system
Description: Evaluation system applied with virtual environment using Pico Neo 2 eye
Study: NCT05016024

Intervention type: DEVICE
Group type: OTHER
Intervention: Colilen IBS
Description: Patients will take Colilen IBS in First or Second Period

Intervention type: DEVICE
Group type: OTHER
Intervention: Colilen IBS
Description: Patients will take Colilen IBS in First or Second Period

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Patients will take PlaceboS in First or Second Period

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Patients will take PlaceboS in First or Second Period
Study: NCT05671523

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Firstly the skin is cleaned with a piece of cotton immersed in alcohol. Then sterilized disposable thin, stainless steel needles (25 × 0.30 mm) will be inserted into the skin over the nodule in A1 pulley anatomic location. The duration of needling will be 1 minute. The needle will be inserted deeply at 45° to the level of metacarpophalangeal level to the nodule. The needle may be inserted into the tendon. This is confirmed by needle movement when the patient ﬂexes and extends the distal phalanx. The needle is withdrawn slowly until this motion ceases, and the needle tip is in the A1 pulley. This will be repeated 2 times per week for 5 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment
Description: Finger splint is designed to stabilize and immobilize a small finger joint. A wide, flat band offers comfortable pressure distribution and control. Contoured finger splint with a comfortable, close fit. The patient will use the splint at night. Can easily be adjusted to accommodate swollen digits. Suitable for a number of finger conditions.~Therapeutic ultrasound is often used by physiotherapists to reduce pain, increase circulation and increase mobility of soft tissues. Additionally, the application of ultrasound can be helpful in the reduction of inflammation, reducing pain and the healing.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional treatment
Description: Finger splint is designed to stabilize and immobilize a small finger joint. A wide, flat band offers comfortable pressure distribution and control. Contoured finger splint with a comfortable, close fit. The patient will use the splint at night. Can easily be adjusted to accommodate swollen digits. Suitable for a number of finger conditions.~Therapeutic ultrasound is often used by physiotherapists to reduce pain, increase circulation and increase mobility of soft tissues. Additionally, the application of ultrasound can be helpful in the reduction of inflammation, reducing pain and the healing.
Study: NCT04724512

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: suture
Description: a type of suture used in entropion surgery

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: suture
Description: a type of suture used in entropion surgery
Study: NCT04866095

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiogram
Description: Transthoracic echocardiogram (TTE) is a widely used and validated imaging technique which involves the study of the heart and great vessels through multiple examination windows. In particular, the subcostal window represents the gold standard for evaluating the diameter of the inferior vena cava (IVC) and its compliance, allowing the physician to obtain valuable information on the volume status of patients. Acquiring images in the subcostal window with a transthoracic echocardiogram (TTE) can be, in some cases, difficult or impossible due to the presence of drainages or surgical wounds: in such cases an alternative could be represented by the trans-hepatic window. This has not been validated in the scientific litterature.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clear Sight system
Description: The Clear Sight System is a non-invasive blood pressure (BP) monitoring system, where the CO is determined analysing the photo-plethysmography curve by a miniaturized pressure cuff and infrared LEDs.~Its main advantage is to assess CO continuously in a completely non-invasive way, following its variations and thereby contributing to the detection of hypovolaemia. Other visualized parameters are: the stroke volume (SV), the systemic vascular resistance (SVR) as well as the BP and the heart rate (HR).
Study: NCT05426018

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SY-009 capsules
Description: 3 capsules each time (3 test drugs), 3 times a day (oral administration before breakfast, lunch, dinner or with meals)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SY-009 capsules
Description: 3 capsules each time (3 test drugs), 3 times a day (oral administration before breakfast, lunch, dinner or with meals)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SY-009 capsules
Description: 3 capsules each time (3 test drugs), 3 times a day (oral administration before breakfast, lunch, dinner or with meals)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SY-009 capsules
Description: 3 capsules each time (3 test drugs), 3 times a day (oral administration before breakfast, lunch, dinner or with meals)
Study: NCT06351982

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Electro Medical Systems AIRFLOW® Prophylaxis Master Device
Description: 1. Disclosure of biofilm with erythrosine,~2. Removal of supragingival and subgingival (up to 4 mm) biofilm and stains with the use of AIRFLOW® Master Piezon® with AIRFLOW® PLUS powder (EMS- Dental, Nyon Switzerland).~3. Supra- and sub- gingival debridement by using the AIRFLOW® Master Piezon® device with Piezon NO PAIN® (EMS-Dental) technology.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand and ultrasonic scalers and curettes
Description: Combination of ultrasonic and hand instrumentation only. Pockets ≥4 mm will be subgingivally debrided using the piezo device according to manufacturer's instructions, and hand curettes will be used until the operator considers the surfaces to be sufficiently clean and free of deposits.
Study: NCT05242341

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: application(APP) teaching
Description: Teaching the use of the APP
Study: NCT04798846

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dorsal plating
Description: Spanning Plate inserted dorsally below tendons Spanning External Fixator by rods inserted in distal radius and metacarpals

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dorsal plating
Description: Spanning Plate inserted dorsally below tendons Spanning External Fixator by rods inserted in distal radius and metacarpals
Study: NCT06493045

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IRL757
Description: IRL757 capsule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule
Study: NCT06138938

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intraoperative abdominal irrigation
Description: All blood clots and other remnants were manually externalized with a sponge holder forceps from the pelvic areas following the uterine incision closure. Then, 1,000 mL of warm saline irrigation was poured into the vesicouterine cavity and aspirated as much as possible in the reverse Trendelenburg position using an aspirator, carefully avoiding any contact with the intestines.
Study: NCT06344871

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroLF
Description: NeuroLF Scan

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional PET scan
Description: Scan on conventional PET system
Study: NCT06174961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Description: 15,000 units of unfractionated heparin administered in the thigh
Study: NCT05760027

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Description: The group of athletes will perform plyometric stability exercises and their usual exercise for 30 days.

Intervention type: OTHER
Group type: OTHER
Intervention: Regular exercise
Description: The group of athletes will perform their usual exercise for 30 days.
Study: NCT06174961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Description: 15,000 units of unfractionated heparin administered in the thigh

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Description: 15,000 units of unfractionated heparin administered in the thigh

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Description: 15,000 units of unfractionated heparin administered in the thigh

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Double-legged cycle ergometer exercise
Description: One hour of double-leg cycle ergometer exercise

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Single-legged cycle ergometer exercise, with unfractionated heparin injection in the exercising leg
Description: One hour of single-leg cycle ergometer exercise, after unfractionated heparin injection in the ipsilateral leg

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Single-legged cycle ergometer exercise, with unfractionated heparin injection in the non-exercising leg
Description: One hour of single-leg cycle ergometer exercise, after unfractionated heparin injection in the ipsilateral leg

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No exercise
Description: No exercise
Study: NCT05818384

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wakaya: Rising Up for Choctaw Youth Curriculum
Description: An experiential, outdoor, nature-based program grounded in Choctaw values. It is a multi-level intervention that increases individual motivation and leadership skills to make healthy behavioral choices for behavior and exercise.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wakaya: Rising Up for Choctaw Youth Curriculum
Description: An experiential, outdoor, nature-based program grounded in Choctaw values. It is a multi-level intervention that increases individual motivation and leadership skills to make healthy behavioral choices for behavior and exercise.